Telesis Bio Inc
NASDAQ:TBIO
Balance Sheet
Balance Sheet Decomposition
Telesis Bio Inc
Telesis Bio Inc
Balance Sheet
Telesis Bio Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
29
|
13
|
83
|
30
|
2
|
|
| Cash |
29
|
13
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
83
|
30
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
13
|
18
|
|
| Total Receivables |
1
|
2
|
4
|
6
|
6
|
|
| Accounts Receivables |
1
|
2
|
4
|
6
|
6
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
2
|
2
|
4
|
|
| Other Current Assets |
0
|
1
|
4
|
3
|
1
|
|
| Total Current Assets |
31
|
17
|
93
|
55
|
30
|
|
| PP&E Net |
1
|
4
|
6
|
9
|
35
|
|
| PP&E Gross |
1
|
4
|
6
|
9
|
35
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
2
|
3
|
|
| Intangible Assets |
3
|
2
|
2
|
2
|
1
|
|
| Goodwill |
3
|
3
|
14
|
15
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
|
| Other Assets |
3
|
3
|
14
|
15
|
3
|
|
| Total Assets |
39
N/A
|
27
-31%
|
116
+333%
|
81
-30%
|
70
-13%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
3
|
|
| Accrued Liabilities |
1
|
2
|
6
|
8
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
4
|
0
|
|
| Total Current Liabilities |
2
|
6
|
10
|
13
|
8
|
|
| Long-Term Debt |
5
|
3
|
14
|
20
|
5
|
|
| Other Liabilities |
1
|
4
|
2
|
2
|
27
|
|
| Total Liabilities |
7
N/A
|
13
+82%
|
25
+90%
|
35
+37%
|
41
+17%
|
|
| Equity | ||||||
| Common Stock |
39
|
39
|
0
|
0
|
29
|
|
| Retained Earnings |
8
|
26
|
65
|
114
|
161
|
|
| Additional Paid In Capital |
1
|
1
|
156
|
160
|
162
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
31
N/A
|
13
-57%
|
91
+575%
|
47
-49%
|
30
-37%
|
|
| Total Liabilities & Equity |
39
N/A
|
27
-31%
|
116
+333%
|
81
-30%
|
70
-13%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
|